GILD

Gilead Sciences Inc

Jun 17 • 04:00PM ET

125.45

-1.78 -1.40 %

Healthcare • Drug Manufacturers - General • USA • Large • NASD

Peers: AMGN REGN VRTX BIIB ABBV BMY LLY MRK ALNY ARGX

| Held by: VTI VOO QQQ IVV SPY VTV XLV VIG QQQM VYM

Scroll to Statements

Index	NDX, S&P 500	P/E	17.07	EPS (ttm)	7.35	Insider Own	0.14%	Shs Outstand	1.24B	Perf Week	3.27%
Market Cap	155.75B	Forward P/E	12.92	EPS next Y	9.71	Insider Trans	-18.22%	Shs Float	1.24B	Perf Month	-3.25%
Enterprise Value	168.03B	PEG	1.40	EPS next Q	-6.94	Inst Own	88.79%	Short Float	2.07%	Perf Quarter	-11.21%
Income	9.22B	P/S	5.23	EPS this Y	-105.08%	Inst Trans	-1.49%	Short Ratio	3.83	Perf Half Y	4.73%
Sales	29.79B	P/B	6.63	EPS next Y	2444.52%	ROA	16.35%	Short Interest	25.73M	Perf YTD	2.21%
Book/sh	18.93	P/C	15.87	EPS next 5Y	9.20%	ROE	43.19%	52W High	157.29 -20.24%	Perf Year	16.16%
Cash/sh	7.91	P/FCF	15.23	EPS past 3/5Y	23.06% 133.64%	ROIC	20.77%	52W Low	104.46 20.09%	Perf 3Y	59.08%
Dividend Est.	3.24 (2.58%)	EV/EBITDA	11.38	Sales past 3/5Y	2.83% 3.63%	Gross Margin	79.41%	Volatility	3.02% 2.73%	Perf 5Y	86.63%
Dividend TTM	3.22 (2.57%)	EV/Sales	5.64	EPS Y/Y TTM	55.01%	Oper. Margin	40.41%	ATR (14)	3.59	Perf 10Y	51.78%
Dividend Ex-Date	Jun 15, 2026	Quick Ratio	1.77	Sales Y/Y TTM	3.83%	Profit Margin	30.94%	RSI (14)	42.17	Recom	1.53
Dividend Gr. 3/5Y	2.67% 3.04%	Current Ratio	1.97	EPS Q/Q	54.29%	SMA20	-2.87%	Beta	0.34	Target Price	160.78
Payout	46.60%	Debt/Eq	0.94	Sales Q/Q	5.09%	SMA50	-5.06%	Rel Volume	1.11	Prev Close	127.23
Employees	17000	LT Debt/Eq	0.89	Earnings	May 07 AMC	SMA200	-3.01%	Avg Volume	6.72M	Price	125.45
IPO	Jan 22, 1992	Option/Short	Yes / Yes	EPS/Sales Surpr.	6.31% 0.67%	Trades		Volume	7,434,582	Change	-1.40%

Affiliate • Advertise • Careers • Contact • Blog • Help • Privacy • Follow us on X • Do Not Sell My Personal Information

Quotes delayed 15 minutes for NASDAQ, NYSE and AMEX.
Copyright © 2007-2026 Finviz.com. All Rights Reserved. Export All Screener Data (CSV)